TuHURA Biosciences, Inc. (HURA) vs Minerva Neurosciences, Inc (NERV)

TuHURA Biosciences, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. TuHURA Biosciences, Inc. and Minerva Neurosciences, Inc are of similar size ($116.6M and $115.6M). Across the 9 metrics below, Minerva Neurosciences, Inc leads on 5 and TuHURA Biosciences, Inc. on 4.

Valuation

Metric HURA NERV Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 6.25 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (30.34%) (1,207.23%) (33.15%)
Free cash flow yield (26.29%) (24.00%) (25.50%)

Profitability

Metric HURA NERV Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.84%) 322.05% (56.36%)
Return on assets (92.31%) (629.71%) (48.04%)
Return on invested capital (74.20%) 0.00% 0.00%

Growth

Metric HURA NERV Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 47.93% (18,347.37%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA NERV Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 0.18 20.14 4.72
Net debt to EBITDA 0.12 5.46 0.96

Dividend

Metric HURA NERV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HURA NERV Biotechnology median
Market cap 116.62m 115.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack